Akums launches first-of-its-kind Lasmiditan dispersible tablets for rapid migraine care
Akums Drugs & Pharmaceuticals has announced the launch of the world’s first Lasmiditan dispersible tablets, marking an…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
migraine
Pfizer launches new Rimegepant oral medication in India for migraine
Pfizer has announced the launch of a Rimegepant ODT in India for acute treatment of migraine, with or without aura, in adults with…
Cadila Pharmaceuticals launches Vasograin EC with US FDA-approved formulation for migraine relief
Reformulated Vasograin EC manufactured in USFDA-approved facility; retains leading position in ergotamine segment
Migraine market to reach $16.4 billion in 7MM by 2033, forecasts GlobalData
CGRP antagonists drive growth, but access and reimbursement barriers remain challenges
Akums launches Lasmiditan Tablet for migraine management
The medication is formulated to interrupt pain signals to the brain and address nerve inflammation contributing to migraine…
ZIM Labs gets marketing authorisation for Rizatriptan orally dissolving film in Portugal
Rizatriptan is widely used for relief from Migraine attacks
Ajanta Pharma receives US FDA approval for migraine drug
Zolmitriptan tablets are part of an 'ever-growing portfolio' that the company has developed for the US market
Ajanta Pharma has…
Jubilant Life Sciences gets US FDA nod
The drug is indicated for the acute treatment of migraine in adults and paediatric patients
Jubilant Life Sciences has received…
New blood biomarker for migraine identified
Women with migraine had an average of 5.6 headache days per month
Researchers have identified a potential new marker found in the…
Novartis in global partnership with Amgen
To develop and commercialise pioneering neuroscience treatments
Novartis has entered into a global collaboration with Amgen to…